Synonyms: Spedra® | Stendra® | TA-1790
avanafil is an approved drug (FDA (2012), EMA (2013))
Compound class:
Synthetic organic
Comment: Avanafil is a phosphodiesterase type 5 inhibitor.
![]() View more information in the IUPHAR Pharmacology Education Project: avanafil |
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. FDA (2012) | EMA (2013) |
IUPAC Name ![]() |
4-[(3-chloro-4-methoxyphenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
8572 | avanafil |
Synonyms ![]() |
Spedra® | Stendra® | TA-1790 |
Database Links ![]() |
|
CAS Registry No. | 330784-47-9 |
ChEBI | CHEBI:66876 |
ChEMBL Ligand | CHEMBL1963681 |
DrugBank Ligand | DB06237 |
DrugCentral Ligand | 4305 |
GtoPdb PubChem SID | 178104020 |
PubChem CID | 9869929 |
RCSB PDB Ligand | E6L |
Search Google for chemical match using the InChIKey | WEAJZXNPAWBCOA-INIZCTEOSA-N |
Search Google for chemicals with the same backbone | WEAJZXNPAWBCOA |
Search PubMed clinical trials | avanafil |
Search PubMed titles | avanafil |
Search PubMed titles/abstracts | avanafil |
UniChem Compound Search for chemical match using the InChIKey | WEAJZXNPAWBCOA-INIZCTEOSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | WEAJZXNPAWBCOA-INIZCTEOSA-N |
Wikipedia | Avanafil |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Avanafil (links to external site)
Cat. No. HY-18252 |